Szewczyk M, Wielkoszyński T, Zakliczyński M, Zembala M, Szumska-Kostrzewska M
Drug Monitoring Laboratory, Silesian Center for Heart Disease, Zabrze, Poland.
Transplant Proc. 2007 Nov;39(9):2870-2. doi: 10.1016/j.transproceed.2007.08.059.
Among cardiac transplantation (OHT) of coronary arterial disease, the pathogenesis can be associated with autoimmunologic effects due to oxidative lipoprotein modification and their change in antigenicity. These factors may lead to lipoprotein vascular changes observed in antiphospholipid syndrome or systemic lupus erythematosus. The aim of the presented study was to evaluate anticardiolipin autoantibodies (ACA) and anti-ox-LDL (antibodies against oxidized LDL) levels in the plasma immunoglobulin IgG class.
The study group consisted of 90 OHT patients (79 men/11 women, age 44 +/- 13); 35 individuals were chosen as a control group. Blood samples were taken twice, in years 2002 and 2004. The investigated group was divided into 2 smaller groups: OHT patients in 2002 and OHT patients before 2002.
OHT patients showed significantly higher ACA concentrations compared with the control group (3.53 vs 1.10 GPL U/mL), whereas anti-ox-LDL levels did not differ considerably (494 vs 385 mU/mL). During long-term observation the significant increase in ACA concentration was observed in both patients groups. Significant differences between the 2 OHT patient groups regarding anti-ox-LDL concentration were demonstrated among samples taken in 2002.
The results may indicate the possible role of autoimmunological processes in OHT development. It is necessary to focus further research on the possibilities of developing secondary antiphospholipid syndrome.
在冠状动脉疾病的心脏移植(原位心脏移植)中,发病机制可能与氧化脂蛋白修饰及其抗原性变化所导致的自身免疫效应有关。这些因素可能导致在抗磷脂综合征或系统性红斑狼疮中观察到的脂蛋白血管变化。本研究的目的是评估血浆免疫球蛋白IgG类中的抗心磷脂自身抗体(ACA)和抗氧化型低密度脂蛋白(抗ox-LDL,针对氧化型低密度脂蛋白的抗体)水平。
研究组由90例原位心脏移植患者组成(79名男性/11名女性,年龄44±13岁);选择35名个体作为对照组。在2002年和2004年采集两次血样。被调查的组被分为两个较小的组:2002年的原位心脏移植患者和2002年之前的原位心脏移植患者。
与对照组相比,原位心脏移植患者的ACA浓度显著更高(3.53对1.10 GPL U/mL),而抗ox-LDL水平没有显著差异(494对385 mU/mL)。在长期观察期间,两个患者组的ACA浓度均显著增加。在2002年采集的样本中,两个原位心脏移植患者组在抗ox-LDL浓度方面存在显著差异。
结果可能表明自身免疫过程在原位心脏移植发展中的可能作用。有必要进一步研究继发性抗磷脂综合征的发生可能性。